<DOC>
	<DOCNO>NCT00035711</DOCNO>
	<brief_summary>To evaluate additional cardiovascular risk factor use data VA HDL Intervention Trial ( VA-HIT ) .</brief_summary>
	<brief_title>VA HDL Intervention Trial ( VA-HIT ) Ancillary Study Data Analysis</brief_title>
	<detailed_description>BACKGROUND : The VA HDL Intervention trial ( VA-HIT ) multicenter , placebo control , randomize trial show gemfibrozil significantly reduce major cardiovascular event 2531 men coronary heart disease , low level low density lipoprotein ( LDL ) cholesterol low level high density lipoprotein ( HDL ) cholesterol . In addition unique lipid profile , VA-HIT population also high prevalence diabetes , impair fast glucose , high fast plasma insulin ; central obesity ; hypertension , component ( together high triglyceride low HDL-cholesterol ) constellation risk factor know metabolic syndrome . Since prior clinical trial enrol type population , VA- HIT database unique resource . DESIGN NARRATIVE : The study use VA-HIT database study additional risk marker measure study population 2,531 men coronary heart disease . Specific analysis : 1 ) association level glucose tolerance , insulin resistance feature metabolic syndrome , occurrence major cardiovascular outcome , gemfibrozil efficacy ; 2 ) effect gemfibrozil progression carotid atherosclerosis , measure B-mode ultrasound ; 3 ) association LDL particle size distribution lipoprotein subclass distribution ; homocysteine ; lipoprotein ( ) ; C-reactive protein , tissue plasminogen activator ; fibrinogen ; factor VII ; major cardiovascular outcome gemfibrozil efficacy . The study completion date list record obtain `` End Date '' enter Protocol Registration Results System ( PRS ) record .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Carotid Artery Diseases</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>No eligibility criterion</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>November 2005</verification_date>
</DOC>